Entresto For Heart
- All
- News
-
New Heart Drugs Struggle To Win Sales As Doctors Hold Back
New heart drugs hailed as breakthrough treatments by researchers are struggling to gain traction among prescribing doctors, posing a headache for makers such as Novartis, which reported more weak sales for its Entresto medicine today.
-
New Heart Drugs Struggle To Win Sales As Doctors Hold Back
New heart drugs hailed as breakthrough treatments by researchers are struggling to gain traction among prescribing doctors, posing a headache for makers such as Novartis, which reported more weak sales for its Entresto medicine on Thursday.
-
New Heart Drugs Struggle To Win Sales As Doctors Hold Back
New heart drugs hailed as breakthrough treatments by researchers are struggling to gain traction among prescribing doctors, posing a headache for makers such as Novartis, which reported more weak sales for its Entresto medicine today.
-
New Heart Drugs Struggle To Win Sales As Doctors Hold Back
New heart drugs hailed as breakthrough treatments by researchers are struggling to gain traction among prescribing doctors, posing a headache for makers such as Novartis, which reported more weak sales for its Entresto medicine on Thursday.
